Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4640 (MIR4640) is a human microRNA gene that encodes a short, non-coding RNA belonging to the miRNA class[1]. MicroRNAs are typically 20–24 nucleotides in length and are involved in the post-transcriptional regulation of gene expression by binding to complementary sequences in the 3’ untranslated regions (3’ UTRs) of target messenger RNAs (mRNAs), leading to mRNA destabilization or translational repression[1][3][4]. MIR4640 is associated with regulatory roles in a variety of cellular processes, such as cell proliferation, differentiation, and survival, and is implicated in diseases like asymptomatic dengue infection and lung non-small cell carcinoma[1]. As with other miRNAs, MIR4640 is not considered a conventional therapeutic target such as a receptor or enzyme but may serve as a molecular biomarker or regulator in specific pathophysiologic contexts[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4640 (MIR4640).